机译:通过预期硼珠胺合并的完全应答与观察完成后骨髓瘤的自体移植后的完全应答(Tuba研究)
Division of Hematology Saitama Medical CenterJichi Medical UniversitySaitama Japan;
Division of Hematology Saitama Medical CenterJichi Medical UniversitySaitama Japan;
Department of HematologySapporo Hokuyu HospitalSapporo Japan;
Department of HematologyToranomon Hospital KajigayaKawasaki Japan;
Department of HematologyTsuchiura Kyodo General HospitalTsuchiura Japan;
Department of Hematology Faculty of MedicineUniversity of TsukubaTsukuba Japan;
Department of Hematology and Clinical ImmunologyYokohama City University HospitalYokohama Japan;
Department of HematologyNTT Medical Center TokyoTokyo Japan;
Department of Medical InformaticsNiigata University Medical and Dental HospitalNiigata Japan;
Division of Hematology Saitama Medical CenterJichi Medical UniversitySaitama Japan;
Department of HematologySapporo Hokuyu HospitalSapporo Japan;
Department of HematologyToranomon HospitalTokyo Japan;
Department of HematologySapporo Hokuyu HospitalSapporo Japan;
Department of HematologyTsuchiura Kyodo General HospitalTsuchiura Japan;
Department of Hematology Faculty of MedicineUniversity of TsukubaTsukuba Japan;
Department of Mathematics Faculty of Science Division IITokyo University of ScienceTokyo Japan;
Department of HematologySapporo Hokuyu HospitalSapporo Japan;
Division of Hematology Saitama Medical CenterJichi Medical UniversitySaitama Japan;
Department of HematologyToranomon HospitalTokyo Japan;
Division of Hematology Saitama Medical CenterJichi Medical UniversitySaitama Japan;
autologous hematopoietic cell transplantation; bortezomib; consolidation; multiple myeloma; targeting complete response;
机译:通过预期硼珠胺合并的完全应答与观察完成后骨髓瘤的自体移植后的完全应答(Tuba研究)
机译:硼替佐米的II期开放标签试验在患有多发性骨髓瘤的患者中进行,这些患者已经进行了自体外周血干细胞移植,但未能获得完全的应答。
机译:移植前后反应对多发性骨髓瘤患者结果的影响:反应的顺序改善和完全反应的实现与更长的生存期相关
机译:血液学反应程度对于确定移植患者的原发性全身淀粉样蛋白病的结果是重要的。实现完整响应的重要性
机译:改善多发性骨髓瘤结果的策略:靶向MEK,HDAC和BCL-2的临床前治疗方法以及优化自体造血细胞移植
机译:自体干细胞移植治疗多发性骨髓瘤后完全反应
机译:硼佐米布整合前线自我同种异体移植:低毒性和频繁免疫蛋白型在高风险或年轻骨髓瘤患者中的完全反应